These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 17673038

  • 1. [Effect of lifestyle adjustment, metformin and rosiglitazone in polycystic ovary syndrome].
    Ma LK, Jin LN, Yu Q, Xu L.
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):294-7. PubMed ID: 17673038
    [Abstract] [Full Text] [Related]

  • 2. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
    Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE.
    Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765
    [Abstract] [Full Text] [Related]

  • 3. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M, Bukan N, Ayvaz G, Karakoç A, Törüner F, Cakir N, Arslan M.
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [Abstract] [Full Text] [Related]

  • 4. [Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].
    Liu ZA, Xue YM, Chen LX, Cai Q, Chen H, Zhang J, Cui QH, Ge J, Yuan T.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):586-90. PubMed ID: 15498183
    [Abstract] [Full Text] [Related]

  • 5. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
    Yilmaz M, Karakoç A, Törüner FB, Cakir N, Tiras B, Ayvaz G, Arslan M.
    Gynecol Endocrinol; 2005 Sep; 21(3):154-60. PubMed ID: 16335907
    [Abstract] [Full Text] [Related]

  • 6. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
    Kilicdag EB, Bagis T, Zeyneloglu HB, Tarim E, Aslan E, Haydardedeoglu B, Erkanli S.
    Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
    [Abstract] [Full Text] [Related]

  • 7. Metformin versus rosiglitazone in the treatment of polycystic ovary syndrome.
    Mitkov M, Pehlivanov B, Terzieva D.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):93-8. PubMed ID: 16360262
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J, Zhu Y, Jiang Y, Cao Y.
    Gynecol Endocrinol; 2008 Jul 01; 24(7):392-8. PubMed ID: 18608522
    [Abstract] [Full Text] [Related]

  • 10. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
    Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS.
    Fertil Steril; 2004 Aug 01; 82(2):421-9. PubMed ID: 15302293
    [Abstract] [Full Text] [Related]

  • 11. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.
    Legro RS, Zaino RJ, Demers LM, Kunselman AR, Gnatuk CL, Williams NI, Dodson WC.
    Am J Obstet Gynecol; 2007 Apr 01; 196(4):402.e1-10; discussion 402.e10-1. PubMed ID: 17403436
    [Abstract] [Full Text] [Related]

  • 12. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
    Khorram O, Helliwell JP, Katz S, Bonpane CM, Jaramillo L.
    Fertil Steril; 2006 May 01; 85(5):1448-51. PubMed ID: 16579997
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
    Ye BL, Yang HY, Zhao JZ, Lin JJ, Lin WQ.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec 01; 38(12):745-8. PubMed ID: 14728846
    [Abstract] [Full Text] [Related]

  • 16. [Effects of metformin on gonadotropin-induced ovulation in patients with polycystic ovary syndrome].
    Zhao JZ, Ye BL, Lin JJ, Lin WQ, Chi HH.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Sep 01; 38(9):545-8. PubMed ID: 14680609
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
    Onalan G, Goktolga U, Ceyhan T, Bagis T, Onalan R, Pabuçcu R.
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec 01; 123(2):204-11. PubMed ID: 16316811
    [Abstract] [Full Text] [Related]

  • 19. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study.
    Elnashar A, Fahmy M, Mansour A, Ibrahim K.
    Fertil Steril; 2007 Aug 01; 88(2):406-9. PubMed ID: 17335818
    [Abstract] [Full Text] [Related]

  • 20. An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome.
    Karimzadeh MA, Javedani M.
    Fertil Steril; 2010 Jun 01; 94(1):216-20. PubMed ID: 19463994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.